Medication Review in Women With Depression and Anxiety

Assessing the Impact of Medication Management Review Service for Females Diagnosed With Depression and Anxiety

This study sought to assess the impact of the MMR service on identifying and resolving TRPs, improving adherence, depression and anxiety scores in females diagnosed with depression and anxiety in Jordan

Participants were recruited into this single-blind parallel randomized controlled trial and randomized into active and control groups. A clinical pharmacist identified TRPs for all participants. Adherence, depression and anxiety scores were assessed. Active group patients received the MMR service: pharmacist-delivered counseling and a letter with recommended changes in the patient's treatment plan was sent to the patient's psychiatrist to be applied. Control group participants did not receive the intervention. Follow-up assessments were completed for all patients at 3 months from baseline. Main outcome measures were TRPs, adherence, depression and anxiety scores.

Inclusion Criteria:

• Jordanian females or residents in Jordan for the last 12 months and planning to stay in Jordan for 6 months (the study follow-up period),
• above the age of 18 years
• diagnosed with depression and/or anxiety for at least 4 weeks duration
• taking medications for depression and/or anxiety

Exclusion Criteria:

• presence of a cognitive problem or sensory impairment which may prevent communication with the patient (reported by the patient's psychiatrist)
• being not able to speak or write Arabic (reported by the patient)